Developer docs
API playgroundTry for free, no card

Search company profiles

Noaber

Full company profile

uuid000bbx4

Namestring
Noaber
Legal namestring
Stichting Noaber Foundation
Websiteurl
noaber.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Noaber Foundation (Stichting Noaber Foundation) is a Dutch ANBI-recognised family foundation established in 2000 by Paul and Mineke Baan, funded with proceeds from the IPO of the Baan Company software business. The foundation pursues systemic change in Dutch healthcare through a hybrid model that combines venture philanthropy (donations funding programmatic work) with impact investments in early-stage health technology companies. Noaber operates four thematic programs — Population Health, Lifestyle, Mental Health and Resilience, and Social Health — and initiates co-creation projects with governments, municipalities, healthcare providers, knowledge institutions, insurers, and communities rather than accepting unsolicited applications.

On the investment side, Noaber Ventures deploys pre-seed and seed capital into digital health startups primarily based in the Benelux, Nordics, DACH, and UK regions. The foundation does not develop proprietary technology; its portfolio companies build the products. Disclosed portfolio products include the mira digital eye-screening platform by Mirantus Health (which raised a €5.5M seed round in November 2025 to expand into Germany, Austria, and Switzerland), the Meela therapist-patient matching platform, the Alba Health gut microbiome test, the Sweetch AI-powered personalised health coach, the Momo Medical BedSense sensor for nursing homes, and Voeding Leeft's lifestyle programs for chronic conditions (reaching ~7,000 patients with three programs included in Dutch basic insurance). Noaber also co-founded the NextGen Ventures fund with Stichting Triade (affiliated with UMCG) and Achmea to invest in medical information technology.

As a public-benefit foundation, Noaber generates no commercial revenue; its operating model is funded by family foundation capital. Its two financial streams are (1) venture philanthropy grants supporting programmatic work, validation, and ecosystem building, and (2) impact investments into startups where financial returns are secondary to measurable health-system outcomes. The foundation is governed by an external board chaired by former Dutch Prime Minister Prof. Dr. Jan Peter Balkenende, with second-generation Baan family members now in substantive leadership roles following a transition completed around 2019–2023. Co-investment partners include Invest-NL, PFZW, and Rabobank (in Stichting GelijkGezond), Mayo Clinic and Achmea (in NextGen Ventures), and Nationale Nederlanden (in the Mental Health and Resilience program).

Short descriptiontext

Noaber Foundation is a Dutch family foundation that drives systemic change in healthcare through four programs and pre-seed/seed impact investments in early-stage digital health startups across the Benelux, Nordics, DACH, and UK regions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersEde, Netherlands
HQ citystring
Ede
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture philanthropy, impact investing, healthcare programs, family foundation, digital health investment
Industry2 codes
PRIMARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAH
International Grantmaking & Development Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code2 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
SIC code1 code
  • Services-Social Services8300
Product category
Venture Philanthropy
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Venture Philanthropy (Donations)
TypeProfessional Services
Description

Noaber provides donations to support programs and projects that contribute to systemic change in healthcare. This is described as 'venture philanthropy' where the goal is serving society through funding innovative initiatives.

noaber.com
2Impact Investments
TypeSubscription Recurring
Description

Noaber invests in companies that generate both financial returns and positive social impact. These impact investments are instruments to help realize their mission of improving health. The focus is on young companies in non-institutionalized fields where market preconditions are not yet fully in place.

noaber.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Noaber Foundation is a Dutch family foundation that pursues systemic change in healthcare through two activities: (1) running four interconnected programs — Population Health, Lifestyle, Mental Health and Resilience, and Social Health — that create preconditions for sustainable innovation via validation, protocol adaptation, reimbursement changes, and mindset shifts; and (2) making impact investments (venture philanthropy) in early-stage (pre-seed to seed) digital health startups based in Benelux, Nordics, DACH and the UK. The foundation combines philanthropic donations with equity-style impact investments through vehicles such as NexGen Ventures.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Reaching approximately 7,000 people with lifestyle programs through Voeding Leeft
+4 more records
Product overview1 text field

Noaber is a family foundation (not a product company) that pursues systemic change in healthcare through two main activities: (1) Programs - interconnected projects focused on Population Health, Lifestyle, Mental Health and Resilience, and Social Health; (2) Impact investments in healthcare technology companies. Noaber does not develop its own products but invests in portfolio companies including Mira (AI eye screening), Meela (mental health matching), Alba Health (microbiome testing), Sweetch (AI health coaching), and Momo Medical (BedSense sensors).

Product and service5 records
1Population Health Program
CategoryHealthcare program
Description

Noaber's Population Health program drives systemic initiatives to keep people healthy longer and address the root causes of unhealthy lifestyles across Dutch society, targeting prevention rather than cure.

2Lifestyle Program
CategoryHealthcare program
Description

Noaber's Lifestyle program supports evidence-based lifestyle interventions for chronic conditions, partnering with organizations such as Voeding Leeft (reaching approximately 7,000 people with Type 2 diabetes, MS, rheumatoid arthritis, IBD and cancer recovery programs, with three programs included in basic insurance plans).

3Mental Health and Resilience Program
CategoryHealthcare program
Description

Noaber's Mental Health and Resilience program works to strengthen mental health of Dutch citizens through partnerships with organizations such as Nationale Nederlanden and Join Us, addressing issues including youth loneliness (13% of youth 15-25 very lonely, 32% somewhat lonely).

4Social Health Program
CategoryHealthcare program
Description

Noaber's Social Health program addresses health inequalities and the social determinants of health, including supporting Stichting GelijkGezond (which targets people with low incomes facing interconnected debt, health, housing and unemployment issues) and publishing policy plans and whitepapers on social health.

5Noaber Ventures Impact Investments
CategoryImpact investing
Description

Noaber's impact investment arm provides early-stage (pre-seed to seed) capital to digital health startups in Benelux, Nordics, DACH and UK regions, focusing on companies developing solutions for healthy and active living, screening/diagnostics, smart disease management, and healthcare system impact. Portfolio includes Meela, Mirantus Health, Voeding Leeft, Sweetch, Alba Health, Momo Medical, Buurtdokters, and Join Us.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Noaber established collaboration with Mayo Clinic in Florida around 2015 as one of the first forms of structural cooperation with other parties.

2NexGen Ventures
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NexGen Ventures is an investment fund created partly on Noaber's initiative, together with Stichting Triade (affiliated with UMCG) and Achmea. The fund invests in companies developing innovations in medical (information) technology.

noaber.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Noaber works closely with Nationale Nederlanden on the Mental Health and Resilience program, collaborating on initiatives to strengthen mental health and resilience in the Netherlands.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Noaber supports the development of a scalable digital intervention in collaboration with Sweetch, their investment company. In the Netherlands, Sweetch works with Voeding Leeft, one of Noaber's Lifestyle program projects.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Gezonde Basisschool van de Toekomst is affiliated with JOGG, in which 212 municipalities and 38 organizations work together for healthy youth. This partnership is described as a 'golden match' for scaling up.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Munich-based social impact investor backing purpose-driven SMEs in DACH. Comparable hybrid model combining venture philanthropy roots with equity investments, though broader than health.

TypeRegional player
Description

Dutch VC backed by ABP pension fund investing in Dutch tech and healthtech at growth stage. Comparable institutional-backed Dutch health exposure, though focused on later-stage cheques than Noaber's seed orientation.

TypeDirect peer
Description

UK charitable foundation (GBP ~30B) funding health research and mental health programs globally. Comparable in combining large-scale grantmaking with venture-style investments (Wellcome Leap, Wellcome Sanger) targeting health-system transformation.

TypeDirect peer
Description

Amsterdam-based life sciences and healthtech VC with €2B+ AUM. Competes for Dutch and European healthtech seed deals, especially medical-technology crossover investments Noaber backs.

TypeBroad incumbent
Description

Global social-entrepreneurship foundation supporting health-system innovators via fellowships and venture support. Comparable systems-change orientation but operates at individual-changemaker level rather than co-investing at seed stage.

TypeDirect peer
Description

Dutch national impact investor (~€1.7B committed) backing sustainability and healthcare innovations. Already co-invests with Noaber in GelijkGezond; competes on overlapping seed-stage impact mandates.

TypeBroad incumbent
Description

Spanish foundation (€6B+ AUM) funding biomedical research, global health and social programs through grants and impact-aligned vehicles. Comparable multi-decade systemic-health orientation at Iberian scale.

TypeDirect peer
Description

Dutch/Belgian healthcare-dedicated venture and growth investor with €1.5B+ AUM. Directly competes for the same Benelux/DACH digital health seed-stage deals Noaber targets, but as a pure commercial fund.

9Novo Nordisk Foundation
TypeDirect peer
Description

Danish enterprise foundation (€1,000B+ AUM) funding health, biotech and sustainability via grants, impact investments and operating companies. Most direct European analog: combines venture philanthropy with strategic equity, focused on systemic health outcomes over decades.

10Bertelsmann Stiftung
TypeBroad incumbent
Description

Large German family-linked foundation (€1B+ AUM) running health, education and social programs with structural policy reform ambition. Comparable multi-program model, but at much larger scale and broader thematic scope.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles20 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment19 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Noaber

Venture Philanthropynoaber.com

Noaber Foundation is a Dutch family foundation that drives systemic change in healthcare through four programs and pre-seed/seed impact investments in early-stage digital health startups across the Benelux, Nordics, DACH, and UK regions.

What Noaber does

Noaber Foundation (Stichting Noaber Foundation) is a Dutch ANBI-recognised family foundation established in 2000 by Paul and Mineke Baan, funded with proceeds from the IPO of the Baan Company software business. The foundation pursues systemic change in Dutch healthcare through a hybrid model that combines venture philanthropy (donations funding programmatic work) with impact investments in early-stage health technology companies. Noaber operates four thematic programs — Population Health, Lifestyle, Mental Health and Resilience, and Social Health — and initiates co-creation projects with governments, municipalities, healthcare providers, knowledge institutions, insurers, and communities rather than accepting unsolicited applications.

On the investment side, Noaber Ventures deploys pre-seed and seed capital into digital health startups primarily based in the Benelux, Nordics, DACH, and UK regions. The foundation does not develop proprietary technology; its portfolio companies build the products. Disclosed portfolio products include the mira digital eye-screening platform by Mirantus Health (which raised a €5.5M seed round in November 2025 to expand into Germany, Austria, and Switzerland), the Meela therapist-patient matching platform, the Alba Health gut microbiome test, the Sweetch AI-powered personalised health coach, the Momo Medical BedSense sensor for nursing homes, and Voeding Leeft's lifestyle programs for chronic conditions (reaching ~7,000 patients with three programs included in Dutch basic insurance). Noaber also co-founded the NextGen Ventures fund with Stichting Triade (affiliated with UMCG) and Achmea to invest in medical information technology.

As a public-benefit foundation, Noaber generates no commercial revenue; its operating model is funded by family foundation capital. Its two financial streams are (1) venture philanthropy grants supporting programmatic work, validation, and ecosystem building, and (2) impact investments into startups where financial returns are secondary to measurable health-system outcomes. The foundation is governed by an external board chaired by former Dutch Prime Minister Prof. Dr. Jan Peter Balkenende, with second-generation Baan family members now in substantive leadership roles following a transition completed around 2019–2023. Co-investment partners include Invest-NL, PFZW, and Rabobank (in Stichting GelijkGezond), Mayo Clinic and Achmea (in NextGen Ventures), and Nationale Nederlanden (in the Mental Health and Resilience program).

Noaber firmographics

Firmographics
Name
Noaber
Legal name
Stichting Noaber Foundation
Website
https://noaber.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
Noaber Foundation is a Dutch family foundation that drives systemic change in healthcare through four programs and pre-seed/seed impact investments in early-stage digital health startups across the Benelux, Nordics, DACH, and UK regions.
Ownership category
akta.pro rank

Noaber industry classification

Industry
Product category
Venture Philanthropy
NAICS
Grantmaking Foundations (813211), Voluntary Health Organizations (813212)
SIC
Services-Social Services (8300)
akta.pro industry
PRIMARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAH
International Grantmaking & Development Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

  • Venture philanthropy
  • Impact investing
  • Healthcare programs
  • Family foundation
  • Digital health investment

Where Noaber is headquartered

Location

Headquarters

HQ city
Ede
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

Noaber business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Venture Philanthropy (Donations): Noaber provides donations to support programs and projects that contribute to systemic change in healthcare. This is described as 'venture philanthropy' where the goal is serving society through funding innovative initiatives.
  2. Impact Investments: Noaber invests in companies that generate both financial returns and positive social impact. These impact investments are instruments to help realize their mission of improving health. The focus is on young companies in non-institutionalized fields where market preconditions are not yet fully in place.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Noaber product offering

Product offering

Core offering

Noaber Foundation is a Dutch family foundation that pursues systemic change in healthcare through two activities: (1) running four interconnected programs — Population Health, Lifestyle, Mental Health and Resilience, and Social Health — that create preconditions for sustainable innovation via validation, protocol adaptation, reimbursement changes, and mindset shifts; and (2) making impact investments (venture philanthropy) in early-stage (pre-seed to seed) digital health startups based in Benelux, Nordics, DACH and the UK. The foundation combines philanthropic donations with equity-style impact investments through vehicles such as NexGen Ventures.

Product overview

Noaber is a family foundation (not a product company) that pursues systemic change in healthcare through two main activities: (1) Programs - interconnected projects focused on Population Health, Lifestyle, Mental Health and Resilience, and Social Health; (2) Impact investments in healthcare technology companies. Noaber does not develop its own products but invests in portfolio companies including Mira (AI eye screening), Meela (mental health matching), Alba Health (microbiome testing), Sweetch (AI health coaching), and Momo Medical (BedSense sensors).

Differentiator

Problem solved

Functional benefit

Products and services

  • Population Health Program Noaber's Population Health program drives systemic initiatives to keep people healthy longer and address the root causes of unhealthy lifestyles across Dutch society, targeting prevention rather than cure.
  • Lifestyle Program Noaber's Lifestyle program supports evidence-based lifestyle interventions for chronic conditions, partnering with organizations such as Voeding Leeft (reaching approximately 7,000 people with Type 2 diabetes, MS, rheumatoid arthritis, IBD and cancer recovery programs, with three programs included in basic insurance plans).
  • Mental Health and Resilience Program Noaber's Mental Health and Resilience program works to strengthen mental health of Dutch citizens through partnerships with organizations such as Nationale Nederlanden and Join Us, addressing issues including youth loneliness (13% of youth 15-25 very lonely, 32% somewhat lonely).
  • Social Health Program Noaber's Social Health program addresses health inequalities and the social determinants of health, including supporting Stichting GelijkGezond (which targets people with low incomes facing interconnected debt, health, housing and unemployment issues) and publishing policy plans and whitepapers on social health.
  • Noaber Ventures Impact Investments Noaber's impact investment arm provides early-stage (pre-seed to seed) capital to digital health startups in Benelux, Nordics, DACH and UK regions, focusing on companies developing solutions for healthy and active living, screening/diagnostics, smart disease management, and healthcare system impact. Portfolio includes Meela, Mirantus Health, Voeding Leeft, Sweetch, Alba Health, Momo Medical, Buurtdokters, and Join Us.

Quantifiable outcome

  • Reaching approximately 7,000 people with lifestyle programs through Voeding Leeft
  • +4 more outcomes

Companies that use Noaber

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Noaber technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Noaber partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered flagship and core.

  • Mayo ClinicflagshipStrategic or Co-development PartnerNoaber established collaboration with Mayo Clinic in Florida around 2015 as one of the first forms of structural cooperation with other parties.
  • NexGen VenturescoreStrategic or Co-development PartnerNexGen Ventures is an investment fund created partly on Noaber's initiative, together with Stichting Triade (affiliated with UMCG) and Achmea. The fund invests in companies developing innovations in medical (information) technology.
  • Nationale NederlandencoreStrategic or Co-development PartnerNoaber works closely with Nationale Nederlanden on the Mental Health and Resilience program, collaborating on initiatives to strengthen mental health and resilience in the Netherlands.
  • SweetchcoreStrategic or Co-development PartnerNoaber supports the development of a scalable digital intervention in collaboration with Sweetch, their investment company. In the Netherlands, Sweetch works with Voeding Leeft, one of Noaber's Lifestyle program projects.
  • JOGG (Jongeren op Gezond Gewicht)coreStrategic or Co-development PartnerGezonde Basisschool van de Toekomst is affiliated with JOGG, in which 212 municipalities and 38 organizations work together for healthy youth. This partnership is described as a 'golden match' for scaling up.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Noaber competitors and assessment

Company assessment

Direct peers

  • BonVenture: Munich-based social impact investor backing purpose-driven SMEs in DACH. Comparable hybrid model combining venture philanthropy roots with equity investments, though broader than health.
  • Wellcome Trust: UK charitable foundation (GBP ~30B) funding health research and mental health programs globally. Comparable in combining large-scale grantmaking with venture-style investments (Wellcome Leap, Wellcome Sanger) targeting health-system transformation.
  • LSP (Life Sciences Partners): Amsterdam-based life sciences and healthtech VC with €2B+ AUM. Competes for Dutch and European healthtech seed deals, especially medical-technology crossover investments Noaber backs.
  • Invest-NL: Dutch national impact investor (~€1.7B committed) backing sustainability and healthcare innovations. Already co-invests with Noaber in GelijkGezond; competes on overlapping seed-stage impact mandates.
  • Gilde Healthcare: Dutch/Belgian healthcare-dedicated venture and growth investor with €1.5B+ AUM. Directly competes for the same Benelux/DACH digital health seed-stage deals Noaber targets, but as a pure commercial fund.
  • Novo Nordisk Foundation: Danish enterprise foundation (€1,000B+ AUM) funding health, biotech and sustainability via grants, impact investments and operating companies. Most direct European analog: combines venture philanthropy with strategic equity, focused on systemic health outcomes over decades.

Regional players

  • INKEF Capital: Dutch VC backed by ABP pension fund investing in Dutch tech and healthtech at growth stage. Comparable institutional-backed Dutch health exposure, though focused on later-stage cheques than Noaber's seed orientation.

Broad incumbents

  • Ashoka: Global social-entrepreneurship foundation supporting health-system innovators via fellowships and venture support. Comparable systems-change orientation but operates at individual-changemaker level rather than co-investing at seed stage.
  • La Caixa Foundation: Spanish foundation (€6B+ AUM) funding biomedical research, global health and social programs through grants and impact-aligned vehicles. Comparable multi-decade systemic-health orientation at Iberian scale.
  • Bertelsmann Stiftung: Large German family-linked foundation (€1B+ AUM) running health, education and social programs with structural policy reform ambition. Comparable multi-program model, but at much larger scale and broader thematic scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Noaber social profiles

Digital presence

Noaber financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Noaber leadership team

Management profile

Number of profiles

Profiles20 records

Noaber funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Noaber M&A and investment

M&A and investment

M&A

Investments19 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Noaber

What does Noaber do?

Noaber Foundation is a Dutch family foundation that pursues systemic change in healthcare through two activities: (1) running four interconnected programs — Population Health, Lifestyle, Mental Health and Resilience, and Social Health — that create preconditions for sustainable innovation via validation, protocol adaptation, reimbursement changes, and mindset shifts; and (2) making impact investments (venture philanthropy) in early-stage (pre-seed to seed) digital health startups based in Benelux, Nordics, DACH and the UK. The foundation combines philanthropic donations with equity-style impact investments through vehicles such as NexGen Ventures.

Is Noaber a public or private company?

Noaber is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Noaber founded?

Noaber was founded in 2000. It employs 11 to 50 people.

Where is Noaber based?

Noaber is headquartered in Ede, Netherlands, in the Europe region.

How does Noaber make money?

Two revenue lines are on record. Venture Philanthropy (Donations) is the primary driver. The others are impact Investments.

Who are Noaber's main competitors?

Direct peers on record are BonVenture, Wellcome Trust, LSP (Life Sciences Partners), Invest-NL, Gilde Healthcare and Novo Nordisk Foundation. INKEF Capital is listed as a regional player. Broad incumbents are Ashoka, La Caixa Foundation and Bertelsmann Stiftung.

Does Noaber have an API?

No public API is recorded for Noaber.

What industry is Noaber in?

Noaber's product category is Venture Philanthropy. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGAKAH, International Grantmaking & Development Foundations. Its NAICS code is 813211 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireCold Plasma Market worth $3.03 billion by 2031 - Exclusive Report by MarketsandMarkets™MarketsandMarkets projects the global cold plasma market to grow from $2.15 billion in 2026 to $3.03 billion by 2031, a 7.1% CAGR. Europe held 33.9% of the market in 2025, and the medical segment is expected to see the highest growth. Asia Pacific is forecast to register the highest growth rate.PharmiWeb.comVenture Medical Leads Strategic Investment in Plasmacure to Advance Breakthrough Cold Plasma Technology for Chronic Wound HealingVenture Medical closed a €6 million Series A investment in Plasmacure, a Dutch MedTech firm developing PLASOMA cold plasma therapy for chronic wounds. The investment, led by Venture Medical with VGZ, Noaber, and others, includes over $10 million for U.S. regulatory approval and market expansion. The therapy showed 2.5 times more wound closure than current standards in a clinical trial.IBB VenturesDigital health app for migraine closes new funding roundBerlin-based startup Newsenselab GmbH has closed a new funding round for its digital health application 'M-sense Migraine,' supported by investors including IBB Ventures, Noaber, and MedTech Entrepreneurs. The company also successfully completed the documentation phase of the EMMA randomized controlled trial to validate the app's efficacy. This financing will be used to expand expertise in developing digital medicines for chronic diseases.HighHTGF News NewsenselabBerlin-based startup Newsenselab GmbH has closed a new financing round led by IBB Ventures, Noaber, and MedTech Entrepreneurs to expand its digital therapeutic app for migraines. The company reported that its app, M-sense Migräne, has helped users manage over 100,000 headache attacks and is preparing to publish results from the EMMA clinical trial in early 2022. This funding supports Newsenselab's efforts to develop additional digital medicines for chronic diseases.StartupJunctureFundIQare: a new fund for South Holland startups in elderly careFundis, Noaber Ventures, and InnovationQuarter launched FundIQare, an incubator fund for elderly and long-term care startups in South Holland. Each partner contributes up to €2 million, with investments up to €500,000 per innovation, and the fund operates regionally first.